121 related articles for article (PubMed ID: 31276628)
21. The diabetic phenotype is preserved in myotubes established from type 2 diabetic subjects: a critical appraisal.
Gaster M
APMIS; 2019 Jan; 127(1):3-26. PubMed ID: 30549138
[TBL] [Abstract][Full Text] [Related]
22. Reduced lipid oxidation in skeletal muscle from type 2 diabetic subjects may be of genetic origin: evidence from cultured myotubes.
Gaster M; Rustan AC; Aas V; Beck-Nielsen H
Diabetes; 2004 Mar; 53(3):542-8. PubMed ID: 14988236
[TBL] [Abstract][Full Text] [Related]
23. Triacylglycerol accumulation is not primarily affected in myotubes established from type 2 diabetic subjects.
Gaster M; Beck-Nielsen H
Biochim Biophys Acta; 2006 Jan; 1761(1):100-10. PubMed ID: 16442843
[TBL] [Abstract][Full Text] [Related]
24. Differential utilization of saturated palmitate and unsaturated oleate: evidence from cultured myotubes.
Gaster M; Rustan AC; Beck-Nielsen H
Diabetes; 2005 Mar; 54(3):648-56. PubMed ID: 15734839
[TBL] [Abstract][Full Text] [Related]
25. Lipid in skeletal muscle myotubes is associated to the donors' insulin sensitivity and physical activity phenotypes.
Bajpeyi S; Myrland CK; Covington JD; Obanda D; Cefalu WT; Smith SR; Rustan AC; Ravussin E
Obesity (Silver Spring); 2014 Feb; 22(2):426-34. PubMed ID: 23818429
[TBL] [Abstract][Full Text] [Related]
26. Impaired fatty acid metabolism in type 2 diabetic skeletal muscle cells is reversed by PPARgamma agonists.
Cha BS; Ciaraldi TP; Park KS; Carter L; Mudaliar SR; Henry RR
Am J Physiol Endocrinol Metab; 2005 Jul; 289(1):E151-9. PubMed ID: 15727952
[TBL] [Abstract][Full Text] [Related]
27. Distinct microRNA and protein profiles of extracellular vesicles secreted from myotubes from morbidly obese donors with type 2 diabetes in response to electrical pulse stimulation.
Aas V; Øvstebø R; Brusletto BS; Aspelin T; Trøseid AS; Qureshi S; Eid DSO; Olstad OK; Nyman TA; Haug KBF
Front Physiol; 2023; 14():1143966. PubMed ID: 37064893
[TBL] [Abstract][Full Text] [Related]
28. Increased pyruvate dehydrogenase kinase expression in cultured myotubes from obese and diabetic individuals.
McAinch AJ; Cornall LM; Watts R; Hryciw DH; O'Brien PE; Cameron-Smith D
Eur J Nutr; 2015 Oct; 54(7):1033-43. PubMed ID: 25311062
[TBL] [Abstract][Full Text] [Related]
29. Characterization of human myotubes from type 2 diabetic and nondiabetic subjects using complementary quantitative mass spectrometric methods.
Thingholm TE; Bak S; Beck-Nielsen H; Jensen ON; Gaster M
Mol Cell Proteomics; 2011 Sep; 10(9):M110.006650. PubMed ID: 21697546
[TBL] [Abstract][Full Text] [Related]
30. Sestrin 3 regulation in type 2 diabetic patients and its influence on metabolism and differentiation in skeletal muscle.
Nascimento EB; Osler ME; Zierath JR
Am J Physiol Endocrinol Metab; 2013 Dec; 305(11):E1408-14. PubMed ID: 24129397
[TBL] [Abstract][Full Text] [Related]
31. Oxidation of intramyocellular lipids is dependent on mitochondrial function and the availability of extracellular fatty acids.
Corpeleijn E; Hessvik NP; Bakke SS; Levin K; Blaak EE; Thoresen GH; Gaster M; Rustan AC
Am J Physiol Endocrinol Metab; 2010 Jul; 299(1):E14-22. PubMed ID: 20442319
[TBL] [Abstract][Full Text] [Related]
32. Insulin resistance and the mitochondrial link. Lessons from cultured human myotubes.
Gaster M
Biochim Biophys Acta; 2007 Jul; 1772(7):755-65. PubMed ID: 17482433
[TBL] [Abstract][Full Text] [Related]
33. Conditioned media from contracting skeletal muscle potentiates insulin secretion and enhances mitochondrial energy metabolism of pancreatic beta-cells.
Barlow J; Solomon TPJ
Metabolism; 2019 Feb; 91():1-9. PubMed ID: 30445139
[TBL] [Abstract][Full Text] [Related]
34. Production and release of acylcarnitines by primary myotubes reflect the differences in fasting fat oxidation of the donors.
Wolf M; Chen S; Zhao X; Scheler M; Irmler M; Staiger H; Beckers J; de Angelis MH; Fritsche A; Häring HU; Schleicher ED; Xu G; Lehmann R; Weigert C
J Clin Endocrinol Metab; 2013 Jun; 98(6):E1137-42. PubMed ID: 23633211
[TBL] [Abstract][Full Text] [Related]
35. Altered dynamics of lipid metabolism in muscle cells from patients with idiopathic inflammatory myopathy is ameliorated by 6 months of training.
Nemec M; Vernerová L; Laiferová N; Balážová M; Vokurková M; Kurdiová T; Oreská S; Kubínová K; Klein M; Špiritović M; Tomčík M; Vencovský J; Ukropec J; Ukropcová B
J Physiol; 2021 Jan; 599(1):207-229. PubMed ID: 33063873
[TBL] [Abstract][Full Text] [Related]
36. Metabolic flexibility is conserved in diabetic myotubes.
Gaster M
J Lipid Res; 2007 Jan; 48(1):207-17. PubMed ID: 17062897
[TBL] [Abstract][Full Text] [Related]
37. Increased FAT/CD36 cycling and lipid accumulation in myotubes derived from obese type 2 diabetic patients.
Aguer C; Foretz M; Lantier L; Hebrard S; Viollet B; Mercier J; Kitzmann M
PLoS One; 2011; 6(12):e28981. PubMed ID: 22194967
[TBL] [Abstract][Full Text] [Related]
38. Energy metabolism in skeletal muscle cells from donors with different body mass index.
Katare PB; Dalmao-Fernandez A; Mengeste AM; Hamarsland H; Ellefsen S; Bakke HG; Kase ET; Thoresen GH; Rustan AC
Front Physiol; 2022; 13():982842. PubMed ID: 36467688
[TBL] [Abstract][Full Text] [Related]
39. Mitochondrial lipid oxidation is impaired in cultured myotubes from obese humans.
Boyle KE; Zheng D; Anderson EJ; Neufer PD; Houmard JA
Int J Obes (Lond); 2012 Aug; 36(8):1025-31. PubMed ID: 22024640
[TBL] [Abstract][Full Text] [Related]
40. Synchronized human skeletal myotubes of lean, obese and type 2 diabetic patients maintain circadian oscillation of clock genes.
Hansen J; Timmers S; Moonen-Kornips E; Duez H; Staels B; Hesselink MK; Schrauwen P
Sci Rep; 2016 Oct; 6():35047. PubMed ID: 27756900
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
